Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia. (Q33357478)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia. |
scientific article |
Statements
Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia (English)
1 reference
Philadelphia chromosome
2 August 2024
Anna Sureda
Marina Carrasco
Miguel de Miguel
Jesùs A Martínez
Eulogio Conde
Joaquin Díaz-Mediavilla
1 November 2003